Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Open accessThe DOI matches its Crossref record; 773 of the 831 references it cites were found in a registry or an index; 177 of the 559 sources its claims cite were checked for support.
Abstract
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders affecting cortisol biosynthesis. Reduced activity of an enzyme required for cortisol production leads to chronic overstimulation of the adrenal cortex and accumulation of precursors proximal to the blocked enzymatic step. The most common form of CAH is caused by steroid 21-hydroxylase deficiency due to mutations in CYP21A2. Since the last publication summarizing CAH in Endocrine Reviews in 2000, there have been numerous new developments. These include more detailed understanding of steroidogenic pathways, refinements in neonatal screening, improved diagnostic measurements utilizing chromatography and mass spectrometry coupled with steroid profiling, and improved genotyping methods. Clinical trials of alternative medications and modes of delivery have been recently completed or are under way. Genetic and cell-based treatments are being explored. A large body of data concerning long-term outcomes in patients affected by CAH, including psychosexual well-being, has been enhanced by the establishment of disease registries. This review provides the reader with current insights in CAH with special attention to these new developments.
Overview
CoChat Summary
TL;DR
This review summarizes current understanding of congenital adrenal hyperplasia (CAH), predominantly 21-hydroxylase deficiency (21OHD), covering steroidogenesis, genetics, diagnosis, management, and long-term outcomes. It emphasizes a phenotypic continuum, newer biomarkers and therapies, and persistent evidence gaps in treatment and surgical care.
Key findings
- 21OHD accounts for approximately 90–99% of CAH; classic CAH incidence is about 1 in 14,000 to 18,000 by newborn screening, while nonclassic (NC) CAH is estimated at ~1 in 200 in the Caucasian population.
- Genotype correlates with the less severely impaired CYP21A2 allele: 96% of individuals with two Group 0 alleles have salt-wasting CAH, whereas 97% of those with at least one Group C allele have NC CAH; residual enzyme activity is ~1–5% in simple virilizing and ~20–50% in NC CAH.
- Long-term sequelae include testicular adrenal rest tumors (TARTs) in males (reported prevalence 14–86%, average 25% in adolescents and 46% in men), adrenal masses in ~20–30% of adults, and increased mortality; adrenal crises caused 42% of deaths in a Swedish cohort, with mean age at death 54.8 years versus 72.8 years in controls.
- Newer concepts include 11-oxo-androgens such as 11-ketotestosterone as biomarkers, the backdoor pathway to dihydrotestosterone, and novel therapies (CRHR1 antagonists, abiraterone, modified-release hydrocortisone, gene/cell-based approaches), though many lack peer-reviewed long-term outcomes.
Methods
- Narrative, multi-authored review resulting from a planned European CAH Symposium postponed due to the COVID-19 pandemic; it covers pathophysiology, diagnostics, management, long-term sequelae, developing-country challenges, and future directions.
- Evidence base is a synthesis of published literature, clinical guidelines (including the 2018 Endocrine Society guideline), registries, observational studies, meta-analyses, and clinical trials; no primary patient cohort or systematic search is described.
- Main analysis is narrative synthesis, with tables and figures summarizing incidence, allele frequencies, treatment dosing, monitoring, and prenatal dexamethasone outcomes.
Limitations
- Stated: there are no large-scale prospective randomized trials for any therapies discussed; evidence is generally low or moderate quality and rests partly on expert opinion, values, and preferences.
- Stated: no evidence-based guidelines for surgical management exist, and there are no studies comparing different feminizing surgery techniques or early versus late surgery; genotype-phenotype correlations are strong but not absolute, and many neuroimaging studies are hindered by small sample size.
- Evident: as a narrative review, it does not report a systematic search strategy, formal risk-of-bias assessment, or quantitative synthesis; conclusions depend on the cited literature and expert consensus.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
86 Valid · 78 Not valid · 186 Not checked · 76 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Supraphysiological dosages of glucocorticoids similar to those used to treat classic CAH patients may be necessary to suppress adrenal androgen production (426).”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Growth
What the sources say
- Disputedcites [426] Livadas, 2019, Management of the female with non-classical congenital adrenal hyperplasia (NCCAH): a patient-oriented approach, Front Endocrinol (Lausanne). sourceExperimental — accuracy not yet measured
In “NCCAH Management From the First Manifestation to the Adult Life” (page unavailable), the paper says glucocorticoids are generally given at replacement, not pharmacological, doses to decrease adrenal androgen production. Its “Management During Childhood” section adds that very high doses are needed to suppress 17-OHP and progesterone, not that supraphysiological doses are necessary to suppress adrenal androgens. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Females do outnumber males in some(12,240,241) although not all (242) retrospective studies in which CAH was clinically diagnosed without neonatal screening.”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Table 7
What the sources say
- Not checked — no full text of the sourcecites [12] Dumic, 2009, Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia between 1995 and 2006, Horm Res. source
- Not checked — no full text of the sourcecites [240] Hird, 2014, No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening, Arch Dis Child. source
- Disputedcites [241] Riedl, 2019, Genotype/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients, Endocr Connect. sourceExperimental — accuracy not yet measured
Citation (242) is attached to “not all,” offering this study as an example of a retrospectively studied, clinically diagnosed prescreening group without a female majority. The Results (Eligible patients; page unavailable) say the opposite: females made up 64% of the prescreening group. The approximately equal sex distribution was in the screened group, which does not fit that clause. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“A single-dose, fixed-sequence study of 8 women given 300 or 600 mg of the CRHR1 antagonist NBI77860 at 2200 (10 PM) showed significant reductions in ACTH and 17OHP over the ensuing 16 hours relative to a control period during which glucocorticoid treatment was withheld (498).”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > D. New medical strategies (Figure 5)
What the sources say
- Disputedcites [498] Sanders, 2018, Melanocortin 2 receptor antagonists in canine pituitary-dependent hypercortisolism: in vitro studies, Vet Res Commun. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 2 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
plainstates a causen = 8- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Excessive nighttime glucocorticoid administration has potential adverse metabolic consequences (371,382).”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Table 7
What the sources say
- Not checked — no full text of the sourcecites [371] Han, 2013, Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia, Clin Endocrinol (Oxf). source
- Partly supportedcites [382] Whitaker, 2014, An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure, Clin Endocrinol (Oxf). sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says cortisol is normally low around midnight and that loss of its rhythm is associated with insulin resistance. It also suggests physiological replacement may help metabolic homeostasis. These passages support a potential metabolic concern, but the paper does not specifically state that excessive nighttime glucocorticoid administration has adverse metabolic consequences. (LLM, conf=0.82)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Low expression of CYP21A2 during the second trimester partially explains the high incidence of false-positives in newborn screens for CAH in premature infants (see section IV.A)(159).”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Pattern of CYP21A2 expression
What the sources say
- Could not verifycites [159] Zhou, 1997, Steroid 21-hydroxylase expression and activity in human lymphocytes, Mol Cell Endocrinol. sourceExperimental — accuracy not yet measured
Section 3.1 reports CYP21 expression in cultured lymphoid cells, including cells from CAH patients, but does not examine expression during the second trimester. Searches for premature infants, newborn screening, and false positives found no passage addressing the proposed explanation. (LLM, conf=0.76)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
207 more claims · 72 with their cited sources checked
Create a free account to see all 426 claims and to verify the 50 references still open.
- It may state two separate claims as one. 172
- Probably not a substantial claim. 64
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been reported that heterozygous TNXB mutations may be associated with the mild joint hypermobility form of EDS [1, 15] and that up to 10% of classic SW-CAH patients harboring in compound heterozygosity a TNXB/CYP21A2 genotype tend to demonstrate an extended phenotype termed CAH-X syndrome [1, 31, 32] (Fig. 2).”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been reported that heterozygous TNXB mutations may be associated with the mild joint hypermobility form of EDS [1, 15] and that up to 10% of classic SW-CAH patients harboring in compound heterozygosity a TNXB/CYP21A2 genotype tend to demonstrate an extended phenotype termed CAH-X syndrome [1, 31, 32] (Fig. 2).”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several reports in European, Mediterranean, Middle Eastern, and Chinese populations confirmed a high frequency of the pathogenic IVS2-13A/C > G and found it to comprise 20 to 25% of the CYP21A2 mutant alleles and to translate to the most severe SW forms of the disease when inherited in homozygosity [1, 4, 27, 39–43].”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“When combined with complementary methods such MLPA for copy number analysis, it provides nearly complete diagnostic coverage, identifying up to 98-99% of classical pathogenic alleles in most populations (1, 16, 76).”
From Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques (2026) · cites this paper as [76]
In the citing paper
“Although CAH is rare, the most common form is caused by steroid 21-hydroxylase deficiency (21-OHD) and is an autosomal-recessive disorder of adrenal steroidogenesis that results from CYP21A2 mutations.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [1]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Sodium chloride supplements 1-2 g (17-24 mEq/day) in infancy”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Graphical Abstract
Reported 24 · recomputed 34
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“A recent meta-analysis of 48 CAH cases, 34 (71%) described symptomatic improvement after bilateral adrenalectomy but with 34 cases (10%) reporting short-term and 13 cases (27%) long-term adverse outcomes”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > D. New medical strategies (Figure 5)
Reported 10 · recomputed 70.833333
Citations
Cites
Items 201–400 of 773
Claahsen-van der Grinten, H. L., Sweep, F. C. G. J., Blickman, J. G., Hermus, A. R. M. M., & Otten, B. J. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0201 · Cited by 142
Self-citationFetal DNA in maternal plasma: biology and diagnostic applications
Lo, Y. M. D. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.12.1903 · Cited by 142
Michaud, K., Matheson, K., Kelly, O., & Anisman, H. (2008) · Stress · doi:10.1080/10253890701727874 · Cited by 141
Hannah-Shmouni, F., Morissette, R., Sinaii, N., Elman, M., Prezant, T. R., Chen, W., Pulver, A., & Merke, D. P. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.46 · Cited by 141
Self-citationSteroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism
Storbeck, K.-H., Schiffer, L., Baranowski, E. S., Chortis, V., Prete, A., Barnard, L., Gilligan, L. C., Taylor, A. E., Idkowiak, J., Arlt, W., et al. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00262 · Cited by 141
Self-citationMonaghan, M. C., Hilliard, M. E., Cogen, F. R., & Streisand, R. (2009) · Families, Systems, & Health · doi:10.1037/a0014770 · Cited by 140
Mendonca, B. B., Inacio, M., Arnhold, I. J. P., Costa, E. M. F., Bloise, W., Martin, R. M., Denes, F. T., Silva, F. A. Q., Andersson, S., Lindqvist, A., et al. (2000) · Medicine · doi:10.1097/00005792-200009000-00003 · Cited by 139
Girgis, R., & Winter, J. S. D. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4320 · Cited by 139
Koetz, K. R., Ventz, M., Diederich, S., & Quinkler, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2036 · Cited by 139
Pai, A. L. H., & McGrady, M. (2014) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsu038 · Cited by 139
Stikkelbroeck, N. M. M. L., Oyen, W. J. G., van der Wilt, G.-J., Hermus, A. R. M. M., & Otten, B. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021074 · Cited by 138
Self-citationFrequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency
Reisch, N., Willige, M., Kohn, D., Schwarz, H.-P., Allolio, B., Reincke, M., Quinkler, M., Hahner, S., & Beuschlein, F. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0161 · Cited by 136
Self-citationLitzelman, K., Catrine, K., Gangnon, R., & Witt, W. P. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9854-2 · Cited by 136
Krone, N., Wachter, I., Stefanidou, M., Roscher, A. A., & Schwarz, H. P. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01359.x · Cited by 135
Self-citationThe external genitalia score (EGS): a European multicenter validation study
van der Straaten, S., Springer, A., Zecic, A., Hebenstreit, D., Tonnhofer, U., Gawlik, A., Baumert, M., Szeliga, K., Debulpaep, S., Desloovere, A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz142 · Cited by 135
Self-citationCharmandari, E., Hindmarsh, P. C., Johnston, A., & Brook, C. G. D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7522 · Cited by 134
Hoimes‐Walker, D. J., Conway, G. S., Honour, J. W., Rumsby, G., & Jacobs, H. S. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02034.x · Cited by 134
Pinquart, M. (2013) · Body Image · doi:10.1016/j.bodyim.2012.10.008 · Cited by 134
Peer victimization among school-aged children with chronic conditions
Sentenac, M., Arnaud, C., Gavin, A., Molcho, M., Gabhainn, S. N., & Godeau, E. (2012) · Epidemiologic Reviews · doi:10.1093/epirev/mxr024 · Cited by 134
Secinti, E., Thompson, E. J., Richards, M., & Gaysina, D. (2017) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12727 · Cited by 134
Barakat, L. P., Patterson, C. A., Daniel, L. C., & Dampier, C. (2008) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-6-60 · Cited by 133
Engberg, H., Butwicka, A., Nordenström, A., Hirschberg, A. L., Falhammar, H., Lichtenstein, P., Nordenskjöld, A., Frisén, L., & Landén, M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.06.017 · Cited by 132
Self-citationHamzavi, I., Tan, E., Shapiro, J., & Lui, H. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.09.025 · Cited by 132
Sartorato, P., Zulian, E., Benedini, S., Mariniello, B., Schiavi, F., Bilora, F., Pozzan, G., Greggio, N., Pagnan, A., Mantero, F., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1711 · Cited by 132
Nonsense mutation causing steroid 21-hydroxylase deficiency
Globerman, H., Amor, M., Parker, K. L., New, M. I., & White, P. C. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113562 · Cited by 130
Self-citationRivkees, S. A., & Crawford, J. D. (2000) · PEDIATRICS · doi:10.1542/peds.106.4.767 · Cited by 130
Quinkler, M., Meyer, B., Bumke-Vogt, C., Grossmann, C., Gruber, U., Oelkers, W., Diederich, S., & Bahr, V (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460789 · Cited by 130
Bhargava, A., Arnold, A. P., Bangasser, D. A., Denton, K. M., Gupta, A., Hilliard Krause, L. M., Mayer, E. A., McCarthy, M., Miller, W. L., Raznahan, A., et al. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa034 · Cited by 130
Self-citationSelf‐esteem of children and adolescents with chronic illness: a meta‐analysis
Pinquart, M. (2013) · Child: Care, Health and Development · doi:10.1111/j.1365-2214.2012.01397.x · Cited by 129
Nakamura, Y., Hornsby, P. J., Casson, P., Morimoto, R., Satoh, F., Xing, Y., Kennedy, M. R., Sasano, H., & Rainey, W. E. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2374 · Cited by 129
Colletti, C. J. M., Wolfe‐Christensen, C., Carpentier, M. Y., Page, M. C., McNall‐Knapp, R. Y., Meyer, W. H., Chaney, J. M., & Mullins, L. L. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21577 · Cited by 128
Neonatal screening for congenital adrenal hyperplasia
van der Kamp, H., & Wit, J. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.151u071 · Cited by 128
Falhammar, H., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0656-0 · Cited by 127
Self-citationStructure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia
Haider, S., Islam, B., D’Atri, V., Sgobba, M., Poojari, C., Sun, L., Yuen, T., Zaidi, M., & New, M. I. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221133110 · Cited by 127
Pasterski, V., Zucker, K. J., Hindmarsh, P. C., Hughes, I. A., Acerini, C., Spencer, D., Neufeld, S., & Hines, M. (2015) · Archives of Sexual Behavior · doi:10.1007/s10508-014-0385-0 · Cited by 127
Mullins, L. L., Wolfe-Christensen, C., Hoff Pai, A. L., Carpentier, M. Y., Gillaspy, S., Cheek, J., & Page, M. (2007) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsm044 · Cited by 127
Almasri, J., Zaiem, F., Rodriguez-Gutierrez, R., Tamhane, S. U., Iqbal, A. M., Prokop, L. J., Speiser, P. W., Baskin, L. S., Bancos, I., & Murad, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01863 · Cited by 127
Self-citationPrenatal diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency) by HLA typing
Pollack, M. S., Levine, L. S., Pang, S., Owens, R. P., Nitowsky, H. M., Dupont, B., Maurer, D., New, M. I., Duchon, M., Merkatz, I. R., et al. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91789-6 · Cited by 126
Olgemöller, B., Roscher, A. A., Liebl, B., & Fingerhut, R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021732 · Cited by 124
Establishing Patient Registries for Rare Diseases: Rationale and Challenges
Boulanger, V., Schlemmer, M., Rossov, S., Seebald, A., & Gavin, P. (2020) · Pharmaceutical Medicine · doi:10.1007/s40290-020-00332-1 · Cited by 124
Glucocorticoid programming of the fetal male hippocampal epigenome
Crudo, A., Suderman, M., Moisiadis, V. G., Petropoulos, S., Kostaki, A., Hallett, M., Szyf, M., & Matthews, S. G. (2013) · Endocrinology · doi:10.1210/en.2012-1980 · Cited by 123
Pall, M., Azziz, R., Beires, J., & Pignatelli, D. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.06.025 · Cited by 123
Meyer-Bahlburg, H. F. L., Dolezal, C., Baker, S. W., Carlson, A. D., Obeid, J. S., & New, M. I. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021129 · Cited by 123
Tamhane, S., Rodriguez-Gutierrez, R., Iqbal, A. M., Prokop, L. J., Bancos, I., Speiser, P. W., & Murad, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01862 · Cited by 123
Self-citationDisorders of steroid 11 beta-hydroxylase isozymes
White, P. C. (1994) · Endocrine Reviews · doi:10.1210/er.15.4.421 · Cited by 122
Self-citationWhitaker, M. J., Debono, M., Huatan, H., Merke, D. P., Arlt, W., & Ross, R. J. (2014) · Clinical Endocrinology · doi:10.1111/cen.12316 · Cited by 121
Self-citationFamilies With Children With Diabetes: Implications of Parent Stress for Parent and Child Health
Helgeson, V. S., Becker, D., Escobar, O., & Siminerio, L. (2012) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsr110 · Cited by 121
Stinson, J., Kohut, S. A., Spiegel, L., White, M., Gill, N., Colbourne, G., Sigurdson, S., Duffy, K. W., Tucker, L., Stringer, E., et al. (2014) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh-2013-0512 · Cited by 121
Dickinson, H., Walker, D. W., Wintour, E. M., & Moritz, K. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00481.2006 · Cited by 120
Bauman, D. R., Steckelbroeck, S., Williams, M. V., Peehl, D. M., & Penning, T. M. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0287 · Cited by 120
Krone, N., Rose, I. T., Willis, D. S., Hodson, J., Wild, S. H., Doherty, E. J., Hahner, S., Parajes, S., Stimson, R. H., Han, T. S., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3343 · Cited by 119
Gidlöf, S., Wedell, A., Guthenberg, C., von Döbeln, U., & Nordenström, A. (2014) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2013.5321 · Cited by 119
Self-citationThe use of adrenalectomy as a treatment for congenital adrenal hyperplasia
Van Wyk, J. J. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.9.3180 · Cited by 119
How safe is long-term prenatal glucocorticoid treatment?
Seckl, J. R. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540370067039 · Cited by 118
Qadir, F., Khan, M. M., Medhin, G., & Prince, M. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-745 · Cited by 118
Current knowledge on the acute regulation of steroidogenesis
Selvaraj, V., Stocco, D. M., & Clark, B. J. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy102 · Cited by 118
Fukami, M., Nishimura, G., Homma, K., Nagai, T., Hanaki, K., Uematsu, A., Ishii, T., Numakura, C., Sawada, H., Nakacho, M., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2816 · Cited by 117
Preimplantation genetic diagnosis at 20 years
Simpson, J. L. (2010) · Prenatal Diagnosis · doi:10.1002/pd.2552 · Cited by 117
Balsamo, A., Cacciari, E., Piazzi, S., Cassio, A., Bozza, D., Pirazzoli, P., & Zappulla, F. (1996) · PEDIATRICS · doi:10.1542/peds.98.3.362 · Cited by 116
Bouvattier, C., Esterle, L., Renoult-Pierre, P., de la Perrière, A. B., Illouz, F., Kerlan, V., Pascal-Vigneron, V., Drui, D., Christin-Maitre, S., Galland, F., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4124 · Cited by 116
Self-citationThomas, J. L., Mason, J. I., Brandt, S., Spencer, B. R., & Norris, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208537200 · Cited by 115
Parental Reports of Stigma Associated with Child’s Disorder of Sex Development
Rolston, A. M., Gardner, M., Vilain, E. J. N., & Sandberg, D. E. (2015) · International Journal of Endocrinology · doi:10.1155/2015/980121 · Cited by 115
Self-citationBone mineral density and body composition in congenital adrenal hyperplasia.
Cameron, F. J., Kaymakci, B., Byrt, E. A., Ebeling, P. R., Warne, G. L., & Wark, J. D. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.7.7608286 · Cited by 114
van der Kamp, H. J., Oudshoorn, C. G. M., Elvers, B. H., van Baarle, M., Otten, B. J., Wit, J. M., & Verkerk, P. H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2136 · Cited by 114
Fertility in patients with congenital adrenal hyperplasia
Reichman, D. E., White, P. C., New, M. I., & Rosenwaks, Z. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.11.002 · Cited by 112
Self-citationLin-Su, K., Vogiatzi, M. G., Marshall, I., Harbison, M. D., Macapagal, M. C., Betensky, B., Tansil, S., & New, M. I. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2128 · Cited by 111
Strandqvist, A., Falhammar, H., Lichtenstein, P., Hirschberg, A. L., Wedell, A., Norrby, C., Nordenskjöld, A., Frisén, L., & Nordenström, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3326 · Cited by 111
Sahakitrungruang, T., Tee, M. K., Blackett, P. R., & Miller, W. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1828 · Cited by 111
Self-citationHouk, C. P., & Lee, P. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0714 · Cited by 111
Kulle, A., Krone, N., Holterhus, P. M., Schuler, G., Greaves, R. F., Juul, A., de Rijke, Y. B., Hartmann, M. F., Saba, A., Hiort, O., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0953 · Cited by 111
Self-citationHines, J. M., Bancos, I., Bancos, C., Singh, R. D., Avula, A. V., Young, W. F., Grebe, S. K., & Singh, R. J. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.271106 · Cited by 111
Helleday, J. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.4.933 · Cited by 111
What Causes Low Rates of Child-Bearing in Congenital Adrenal Hyperplasia?
Meyer-Bahlburg, H. F. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5718 · Cited by 110
(1988) · PubMed · Cited by 110
Self-citationRoen, K. (2019) · The Journal of Sex Research · doi:10.1080/00224499.2019.1578331 · Cited by 110
Narasaka, T., Suzuki, T., Moriya, T., & Sasano, H. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00445-7 · Cited by 109
Nordenström, A., Thilén, A., Hagenfeldt, L., Larsson, A., & Wedell, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5651 · Cited by 108
Self-citationBachega, T. A. S. S., Billerbeck, A. E. C., Madureira, G., Marcondes, J. A. M., Longui, C. A., Leite, M. V., Arnhold, I. J. P., & Mendonca, B. B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5350 · Cited by 108
Effects into adulthood of single or repeated antenatal corticosteroids in sheep
Moss, T. J. M., Doherty, D. A., Nitsos, I., Sloboda, D. M., Harding, R., & Newnham, J. P. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.06.065 · Cited by 108
Hansen, J. A., Weissbrod, C. S., Schwartz, D. D., & Taylor, W. P. (2012) · Families Systems & Health · doi:10.1037/a0027519 · Cited by 108
Leveroni, C. L., & Berenbaum, S. A. (1998) · Developmental Neuropsychology · doi:10.1080/87565649809540714 · Cited by 107
Moisan, A. M., Ricketts, M. L., Tardy, V., Desrochers, M., Mébarki, F., Chaussain, J.-L., Cabrol, S., Raux-Demay, M. C., Forest, M. G., Sippell, W. G., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6288 · Cited by 107
Turcu, A. F., Mallappa, A., Elman, M. S., Avila, N. A., Marko, J., Rao, H., Tsodikov, A., Auchus, R. J., & Merke, D. P. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3989 · Cited by 107
Self-citationLong-Term Outcome of Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Bachelot, A., Plu-Bureau, G., Thibaud, E., Laborde, K., Pinto, G., Samara, D., Nihoul-Fékété, C., Kuttenn, F., Polak, M., & Touraine, P. (2007) · Hormone Research in Paediatrics · doi:10.1159/000098017 · Cited by 106
Self-citationClinical outcomes in the management of congenital adrenal hyperplasia
Falhammar, H., & Thorén, M. (2012) · Endocrine · doi:10.1007/s12020-011-9591-x · Cited by 106
Self-citationLong Term Outcome in Adult Males with Classic Congenital Adrenal Hyperplasia
Cabrera, M. S. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.7.3070 · Cited by 105
Current status of neonatal screening for congenital adrenal hyperplasia
Pang, S., & Shook, M. K. (1997) · Current Opinion in Pediatrics · doi:10.1097/00008480-199708000-00018 · Cited by 104
Idkowiak, J., Randell, T., Dhir, V., Patel, P., Shackleton, C. H. L., Taylor, N. F., Krone, N., & Arlt, W. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2413 · Cited by 104
King, J. A., Wisniewski, A. B., Bankowski, B. J., Carson, K. A., Zacur, H. A., & Migeon, C. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0745 · Cited by 104
Fitness, J., Dixit, N., Webster, D., Torresani, T., Pergolizzi, R., Speiser, P. W., & Day, D. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5550 · Cited by 103
Gleeson, H., Davis, J., Jones, J., O'Shea, E., & Clayton, P. E. (2013) · Clinical Endocrinology · doi:10.1111/cen.12053 · Cited by 103
Marsh, C. A., & Auchus, R. J. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.11.011 · Cited by 103
Self-citationNermoen, I., Rørvik, J., Holmedal, S. H., Hykkerud, D. L., Fougner, K. J., Svartberg, J., Husebye, E. S., & Løvås, K. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04151.x · Cited by 103
Falhammar, H., Filipsson Nyström, H., Wedell, A., & Thorén, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0877 · Cited by 103
Self-citationHow Many Deaths Can Be Prevented by Newborn Screening for Congenital Adrenal Hyperplasia?
Grosse, S. D., & Van Vliet, G. (2007) · Hormone Research in Paediatrics · doi:10.1159/000098400 · Cited by 102
Balsamo, A., Cicognani, A., Baldazzi, L., Barbaro, M., Baronio, F., Gennari, M., Bal, M., Cassio, A., Kontaxaki, K., & Cacciari, E. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030123 · Cited by 102
Mercè Fernández‐Balsells, M., Muthusamy, K., Smushkin, G., Lampropulos, J. F., Elamin, M. B., Abu Elnour, N. O., Elamin, K. B., Agrwal, N., Gallegos‐Orozco, J. F., Lane, M. A., et al. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03826.x · Cited by 101
Hall, C. M., Jones, J. A., Meyer-Bahlburg, H. F. L., Dolezal, C., Coleman, M., Foster, P., Price, D. A., & Clayton, P. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030696 · Cited by 101
Wudy, S. A., Hartmann, M. F., & Remer, T. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00495.2006 · Cited by 101
Self-citationHirvikoski, T., Nordenström, A., Lindholm, T., Lindblad, F., Ritzén, E. M., & Lajic, S. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0280 · Cited by 101
Self-citationWhat is the Agenda of the Intersex Patient Advocacy Movement?
Chase, C. (2003) · The Endocrinologist · doi:10.1097/01.ten.0000081687.21823.d4 · Cited by 101
Manoli, I., Kanaka‐Gantenbein, C., Voutetakis, A., Maniati‐Christidi, M., & Dacou‐Voutetakis, C. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01645.x · Cited by 100
Sandberg, D. E., Gardner, M., Callens, N., Mazur, T., & the DSD‐TRN Psychosocial Workgroup, T. D. A. A. N. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31561 · Cited by 99
Self-citationMarino, R., Ramirez, P., Galeano, J., Perez Garrido, N., Rocco, C., Ciaccio, M., Warman, D. M., Guercio, G., Chaler, E., Maceiras, M., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04123.x · Cited by 98
Pregnancy outcomes in women with congenital virilizing adrenal hyperplasia
Lo, J. C., & Grumbach, M. M. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70027-6 · Cited by 98
Falhammar, H., Butwicka, A., Landén, M., Lichtenstein, P., Nordenskjöld, A., Nordenström, A., & Frisén, L. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3707 · Cited by 98
Self-citationSirianni, R., Rehman, K. S., Carr, B. R., Parker, C. R., & Rainey, W. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0865 · Cited by 98
Merza, Z., Rostami‐Hodjegan, A., Memmott, A., Doane, A., Ibbotson, V., Newell‐Price, J., Tucker, G. T., & Ross, R. J. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02544.x · Cited by 98
Słowikowska-Hilczer, J., Hirschberg, A. L., Claahsen-van der Grinten, H., Reisch, N., Bouvattier, C., Thyen, U., Cohen Kettenis, P., Roehle, R., Köhler, B., Nordenström, A., et al. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.08.013 · Cited by 98
Self-citationRegulation of the gene for estrogenic 17-ketosteroid reductase lying on chromosome 17cen–q25.
Tremblay, Y., Ringler, G. E., Morel, Y., Mohandas, T. K., Labrie, F., Strauss, J. F., & Miller, W. L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47083-x · Cited by 97
Self-citationSchwarz, E., Liu, A., Randall, H., Haslip, C., Keune, F., Murray, M., Longo, N., & Pasquali, M. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181aa3777 · Cited by 97
Drake, A. J., Raubenheimer, P. J., Kerrigan, D., McInnes, K. J., Seckl, J. R., & Walker, B. R. (2010) · Endocrinology · doi:10.1210/en.2009-1088 · Cited by 97
Quintos, J. B. Q., Vogiatzi, M. G., Harbison, M. D., & New, M. I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7412 · Cited by 96
Tardy-Guidollet, V., Menassa, R., Costa, J.-M., David, M., Bouvattier-Morel, C., Baumann, C., Houang, M., Lorenzini, F., Philip, N., Odent, S., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2895 · Cited by 96
Prete, A., Taylor, A. E., Bancos, I., Smith, D. J., Foster, M. A., Kohler, S., Fazal-Sanderson, V., Komninos, J., O’Neil, D. M., Vassiliadi, D. A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa133 · Cited by 96
Self-citationHershkovitz, E., Parvari, R., Wudy, S. A., Hartmann, M. F., Gomes, L. G., Loewental, N., & Miller, W. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0051 · Cited by 95
Self-citationPrednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency
Punthakee, Z., Legault, L., & Polychronakos, C. (2003) · The Journal of Pediatrics · doi:10.1067/s0022-3476(03)00294-4 · Cited by 95
Paul, A., Drecourt, A., Petit, F., Deguine, D. D., Vasnier, C., Oufadem, M., Masson, C., Bonnet, C., Masmoudi, S., Mosnier, I., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.09.007 · Cited by 95
El-Maouche, D., Hargreaves, C. J., Sinaii, N., Mallappa, A., Veeraraghavan, P., & Merke, D. P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00208 · Cited by 93
Self-citationCongenital adrenal hyperplasia: time to replace 17OHP with 21-deoxycortisol
Miller, W. L. (2019) · Hormone Research in Paediatrics · doi:10.1159/000501396 · Cited by 93
Self-citationJääskeläinen, J., & Voutilainen, R. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.8620871.x · Cited by 92
Mooij, C. F., Kroese, J. M., Claahsen‐van der Grinten, H. L., Tack, C. J., & Hermus, A. R. M. M. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03690.x · Cited by 92
Self-citationBinet, A., Lardy, H., Geslin, D., Francois-Fiquet, C., & Poli-Merol, M. L. (2016) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2015.10.004 · Cited by 91
Mermejo, L. M., Elias, L. L. K., Marui, S., Moreira, A. C., Mendonca, B. B., & de Castro, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1552 · Cited by 91
Effect of newborn screening for congenital adrenal hyperplasia
Brosnan, P. G., Brosnan, C. A., Kemp, S. F., Domek, D. B., Jelley, D. H., Blackett, P. R., & Riley, W. J. (1999) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.153.12.1272 · Cited by 91
Extraadrenal 21-Hydroxylation by CYP2C19 and CYP3A4: Effect on 21-Hydroxylase Deficiency
Gomes, L. G., Huang, N., Agrawal, V., Mendonça, B. B., Bachega, T. A. S. S., & Miller, W. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1174 · Cited by 91
Self-citationNella, A. A., Mallappa, A., Perritt, A. F., Gounden, V., Kumar, P., Sinaii, N., Daley, L.-A., Ling, A., Liu, C.-Y., Soldin, S. J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1916 · Cited by 91
Self-citationGussinyé, M., Carrascosa, A., Potau, N., Enrubia, M., Vicens-Calvet, E., Ibáñez, L., & Yeste, D. (1997) · PEDIATRICS · doi:10.1542/peds.100.4.671 · Cited by 90
l'Allemand, D. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.12.4562 · Cited by 90
Mulatero, P., Curnow, K. M., Aupetit-Faisant, B., Foekling, M., Gomez-Sanchez, C., Veglio, F., Jeunemaitre, X., Corvol, P., & Pascoe, L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5237 · Cited by 88
Psychiatric characterization of children with genetic causes of hyperandrogenism
Mueller, S. C., Ng, P., Sinaii, N., Leschek, E. W., Green-Golan, L., VanRyzin, C., Ernst, M., & Merke, D. P. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0693 · Cited by 88
Self-citationTajima, T., Okada, T., Ma, X.-M., Ramsey, W. J., Bornstein, S. R., & Aguilera, G. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301018 · Cited by 88
Avila, N. A., Shawker, T. S., Jones, J. V., Cutler, G. B., & Merke, D. P. (1999) · American Journal of Roentgenology · doi:10.2214/ajr.172.5.10227495 · Cited by 87
Self-citationParajes, S., Quinteiro, C., Domínguez, F., & Loidi, L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002138 · Cited by 87
Height, Bone Mineral Density and Bone Markers in Congenital Adrenal Hyperplasia
Paganini, C., Radetti, G., Livieri, C., Braga, V., Migliavacca, D., & Adami, S. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053253 · Cited by 87
Whittle, E., & Falhammar, H. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00136 · Cited by 87
Self-citationNewborn Screening for Congenital Adrenal Hyperplasia inthe Netherlands
Van der Kamp, H. J., Noordam, K., Elvers, B., Van Baarle, M., Otten, B. J., & Verkerk, P. H. (2001) · PEDIATRICS · doi:10.1542/peds.108.6.1320 · Cited by 86
Elimination of the male reproductive tract in the female embryo is promoted by COUP-TFII in mice
Zhao, F., Franco, H. L., Rodriguez, K. F., Brown, P. R., Tsai, M.-J., Tsai, S. Y., & Yao, H. H.-C. (2017) · Science · doi:10.1126/science.aai9136 · Cited by 86
Fernandez, P. M., Brunel, F., Jimenez, M. A., Saez, J. M., Cereghini, S., & Zakin, M. M. (2000) · Endocrinology · doi:10.1210/endo.141.7.7562 · Cited by 85
Jenkins-Jones, S., Parviainen, L., Porter, J., Withe, M., Whitaker, M. J., Holden, S. E., Morgan, C. L., Currie, C. J., & Ross, R. J. M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0895 · Cited by 85
Sex hormones and prostate cancer
Auchus, R. J., & Sharifi, N. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-051418-060357 · Cited by 85
Self-citationAbundant adrenal-specific transcription of the human P450c21A “pseudogene.”
Bristow, J., Gitelman, S. E., Tee, M. K., Staels, B., & Miller, W. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31473-x · Cited by 84
Self-citationInterventions for Female Pattern Hair Loss
van Zuuren, E. J., & Fedorowicz, Z. (2017) · JAMA Dermatology · doi:10.1001/jamadermatol.2016.5790 · Cited by 84
Brady, A. M., Deighton, J., & Stansfeld, S. A. (2020) · Development and Psychopathology · doi:10.1017/s0954579420000206 · Cited by 83
Rubtsov, P., Karmanov, M., Sverdlova, P., Spirin, P., & Tiulpakov, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1118 · Cited by 82
Reisch, N., Rottenkolber, M., Greifenstein, A., Krone, N., Schmidt, H., Reincke, M., Schwarz, H.-P., & Beuschlein, F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3181 · Cited by 82
Self-citationMerke, D. P., Chen, W., Morissette, R., Xu, Z., Van Ryzin, C., Sachdev, V., Hannoush, H., Shanbhag, S. M., Acevedo, A. T., Nishitani, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3148 · Cited by 82
Self-citationClinical, genetic and enzymatic characterization of P450 oxidoreductase deficiency in four patients
Sahakitrungruang, T., Huang, N., Tee, M. K., Agrawal, V., Russell, W. E., Crock, P., Murphy, N., Migeon, C. J., & Miller, W. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1460 · Cited by 82
Self-citationSciannamblo, M., Russo, G., Cuccato, D., Chiumello, G., & Mora, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2823 · Cited by 82
Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia
Falhammar, H., Filipsson Nyström, H., Wedell, A., Brismar, K., & Thorén, M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0865 · Cited by 82
Self-citationNandagopal, R., Sinaii, N., Avila, N. A., Van Ryzin, C., Chen, W., Finkielstain, G. P., Mehta, S. P., McDonnell, N. B., & Merke, D. P. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0019 · Cited by 81
Self-citationGüran, T., Tezel, B., Çakır, M. D., Akıncı, A., Orbak, Z., Keskın, M., Eklioğlu, B. S., Özön, A., Özbek, M. N., Karagüzel, G., et al. (2020) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2020.2019.0182 · Cited by 81
Biochemical and genetic diagnosis of 21-hydroxylase deficiency
Falhammar, H., Wedell, A., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0731-6 · Cited by 80
Self-citationERNST, M., MAHEU, F., SCHROTH, E., HARDIN, J., GOLAN, L., CAMERON, J., ALLEN, R., HOLZER, S., NELSON, E., & PINE, D. (2007) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2007.01.019 · Cited by 80
Hirvikoski, T., Nordenström, A., Wedell, A., Ritzén, M., & Lajic, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1222 · Cited by 80
Self-citationZhao, B., Lei, L., Kagawa, N., Sundaramoorthy, M., Banerjee, S., Nagy, L. D., Guengerich, F. P., & Waterman, M. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.323501 · Cited by 80
Repping-Wuts, H. J. W. J., Stikkelbroeck, N. M. M. L., Noordzij, A., Kerstens, M., & Hermus, A. R. M. M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-1094 · Cited by 80
Self-citationWu, D. A., & Chung, B. C. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115334 · Cited by 80
Quintos, J. B. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.4.1511 · Cited by 80
Bachega, T. A. S. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.12.4416 · Cited by 80
Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia
Guo, C., Weetman, A. P., & Eastell, R. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.00851.x · Cited by 79
Hormones, context, and “brain gender”: a review of evidence from congenital adrenal hyperplasia
Jordan-Young, R. M. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2011.08.026 · Cited by 79
Effects of fifteen PBDE metabolites, DE71, DE79 and TBBPA on steroidogenesis in the H295R cell line
Song, R., He, Y., Murphy, M. B., Yeung, L. W. Y., Yu, R. M. K., Lam, M. H. W., Lam, P. K. S., Hecker, M., Giesy, J. P., Wu, R. S. S., et al. (2008) · Chemosphere · doi:10.1016/j.chemosphere.2008.01.032 · Cited by 79
Coulm, B. (2012) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2011.774 · Cited by 78
Cell Therapy for Type 1 Diabetes: Current and Future Strategies
Aghazadeh, Y., & Nostro, M. C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0863-6 · Cited by 78
Kyriakou, A., Dessens, A., Bryce, J., Iotova, V., Juul, A., Krawczynski, M., Nordenskjöld, A., Rozas, M., Sanders, C., Hiort, O., et al. (2016) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-016-0534-8 · Cited by 78
Self-citationLee, P. A., Houk, C. P., & Husmann, D. A. (2010) · Journal of Urology · doi:10.1016/j.juro.2010.03.116 · Cited by 77
Profiles of 21-Carbon Steroids in 21-Hydroxylase Deficiency
Turcu, A. F., Rege, J., Chomic, R., Liu, J., Nishimoto, H. K., Else, T., Moraitis, A. G., Palapattu, G. S., Rainey, W. E., & Auchus, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1023 · Cited by 77
Self-citationTomalik-Scharte, D., Maiter, D., Kirchheiner, J., Ivison, H. E., Fuhr, U., & Arlt, W. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0764 · Cited by 77
Al Alawi, A. M., Nordenström, A., & Falhammar, H. (2019) · Endocrine · doi:10.1007/s12020-018-01835-3 · Cited by 77
Self-citationLong Term Outcome in Adult Males With Classic Congenital Adrenal Hyperplasia
Jarow, J. P. (2002) · The Journal of Urology · doi:10.1097/00005392-200208000-00120 · Cited by 77
Braga, L. H., & Pippi Salle, J. L. (2009) · European Journal of Pediatric Surgery · doi:10.1055/s-0029-1233490 · Cited by 76
Meyer-Bahlburg, H. F. L., Dolezal, C., Haggerty, R., Silverman, M., & New, M. I. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0789 · Cited by 76
Sex differences in 11-oxygenated androgen patterns across adulthood
Davio, A., Woolcock, H., Nanba, A. T., Rege, J., O’Day, P., Ren, J., Zhao, L., Ebina, H., Auchus, R., Rainey, W. E., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa343 · Cited by 76
Self-citationFitness, J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.3.960 · Cited by 76
Bryan, S. M., Honour, J. W., & Hindmarsh, P. C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0630 · Cited by 75
Final Adult Height in Children with Congenital Adrenal Hyperplasia Treated with Growth Hormone
Lin-Su, K., Harbison, M. D., Lekarev, O., Vogiatzi, M. G., & New, M. I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2699 · Cited by 75
Disorders of sex development (DSD): clinical service delivery in the United States
Rolston, A. M., Gardner, M., van Leeuwen, K., Mohnach, L., Keegan, C., Délot, E., Vilain, E., Sandberg, D. E., Advocacy, M. O. T. D., & Advisory Network Accord Alliance (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31558 · Cited by 75
Self-citationBaumgartner-Parzer, S. M., Schulze, E., Waldhäusl, W., Pauschenwein, S., Rondot, S., Nowotny, P., Meyer, K., Frisch, H., Waldhauser, F., & Vierhapper, H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7898 · Cited by 74
Interleukin-3 and interleukin-6 stimulate cortisol secretion from adult human adrenocortical cells
Weber, M. M., Michl, P., Auernhammer, C. J., & Engelhardt, D. (1997) · Endocrinology · doi:10.1210/endo.138.5.5239 · Cited by 74
Jones, C. M., Mallappa, A., Reisch, N., Nikolaou, N., Krone, N., Hughes, B. A., O’Neil, D. M., Whitaker, M. J., Tomlinson, J. W., Storbeck, K.-H., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2855 · Cited by 74
Self-citationCarrera, P., Bordone, L., Azzani, T., Brunelli, V., Garancini, M. P., Chiumello, G., & Ferrari, M. (1996) · Human Genetics · doi:10.1007/s004390050280 · Cited by 73
Difference in transcriptional activity of two homologous CYP21A genes.
Chang, S. F., & Chung, B. C. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.10.8544841 · Cited by 73
Subbarayan, A., Dattani, M. T., Peters, C. J., & Hindmarsh, P. C. (2014) · Clinical Endocrinology · doi:10.1111/cen.12265 · Cited by 73
Sánchez-Guijo, A., Oji, V., Hartmann, M. F., Traupe, H., & Wudy, S. A. (2015) · Journal of Lipid Research · doi:10.1194/jlr.d061499 · Cited by 73
Self-citationWedell, A. (1998) · Acta Paediatrica · doi:10.1111/j.1651-2227.1998.tb00968.x · Cited by 73
Developmental changes in renal tubular transport-an overview
Gattineni, J., & Baum, M. (2015) · Pediatric Nephrology · doi:10.1007/s00467-013-2666-6 · Cited by 73
Impaired Cognitive Function in Women with Congenital Adrenal Hyperplasia
Johannsen, T. H., Ripa, C. P. L., Reinisch, J. M., Schwartz, M., Mortensen, E. L., & Main, K. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1959 · Cited by 72
Management of Congenital Adrenal Hyperplasia: Results of the ESPE Questionnaire
Riepe, F. G., Krone, N., Viemann, M., Partsch, C.-J., & Sippell, W. G. (2002) · Hormone Research in Paediatrics · doi:10.1159/000065492 · Cited by 72
Self-citationIqbal, M., Moisiadis, V. G., Kostaki, A., & Matthews, S. G. (2012) · Endocrinology · doi:10.1210/en.2012-1054 · Cited by 72
Barnard, M., Quanson, J. L., Mostaghel, E., Pretorius, E., Snoep, J. L., & Storbeck, K.-H. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.06.013 · Cited by 72
MANAGEMENT OF ENDOCRINE DISEASE: Gonadal dysfunction in congenital adrenal hyperplasia
Claahsen-van der Grinten, H. L., Stikkelbroeck, N., Falhammar, H., & Reisch, N. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1093 · Cited by 72
Self-citationStikkelbroeck, N. M. L., Hermus, A. M. M., Schouten, D., Suliman, H., Jager, G., Braat, D. M., & Otten, B. (2004) · European Radiology · doi:10.1007/s00330-004-2329-x · Cited by 71
Self-citationLee, T. C., Miller, W. L., & Auchus, R. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5646 · Cited by 71
Self-citationPituitary gonadal axis and child rate in males with classical 21-hydroxylase deficiency
Jääskeläinen, J., Kiekara, O., Hippeläinen, M., & Voutilainen, R. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03343671 · Cited by 71
Kamrath, C., Wettstaedt, L., Boettcher, C., Hartmann, M. F., & Wudy, S. A. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.12.016 · Cited by 71
Self-citationElevated amniotic fluid concentration of 17 α-hydroxyprogesterone in congenital adrenal hyperplasia
Frasier, S. D., Thorneycroft, I. H., Weiss, B. A., & Horton, R. (1975) · The Journal of Pediatrics · doi:10.1016/s0022-3476(75)80498-7 · Cited by 71
Clinical course of adrenal myelolipoma: A long-term longitudinal follow-up study
Hamidi, O., Raman, R., Lazik, N., Iniguez‐Ariza, N., McKenzie, T. J., Lyden, M. L., Thompson, G. B., Dy, B. M., Young, W. F., & Bancos, I. (2020) · Clinical Endocrinology · doi:10.1111/cen.14188 · Cited by 71
Araújo, R. S., Mendonca, B. B., Barbosa, A. S., Lin, C. J., Marcondes, J. A. M., Billerbeck, A. E. C., & Bachega, T. A. S. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2163 · Cited by 70
JÄÄSKELÄINEN, J., HIPPELÄINEN, M., KIEKARA, O., & VOUTILAINEN, R. (2000) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2000.079008687.x · Cited by 70
Research works printed but not linked: 2
- McCann-Crosby, 2014, Non classic CAH; targets of treatment and transition, Pediatr Endocr Rev., 12, 224
- Auchus, 2012, Abiraterone acetate added to physiologic hydrocortisone dosing safely controls androgen excess in adult women with classical 21-hydroxylase deficiency, Endocr Rev., 33, SUN-LB2
Cited by
Overview of the 2022 WHO Classification of Adrenal Cortical Tumors
Mete, O., Erickson, L. A., Juhlin, C. C., de Krijger, R. R., Sasano, H., Volante, M., & Papotti, M. G. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09710-8 · Cited by 343
Clinical practice guidelines for the care of girls and women with Turner syndrome.
Gravholt, C. H., Andersen, N. H., Christin-Maitre, S., Davis, S. M., Duijnhouwer, A., Gawlik, A., Maciel-Guerra, A. T., Gutmark-Little, I., Fleischer, K., Hong, D., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae050 · Cited by 224
Self-citationManagement challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Self-citationGlucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations
Alcubierre, D. D., Ferrari, D., Mauro, G. C. D., Isidori, A. M., Tomlinson, J., & Pofi, R. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02091-7 · Cited by 77
“In the most severe Salt-Wasting (SW-CAH) form, there is little or no residual enzyme activity, whereas patients with the Simple-Virilizing (SV-CAH) form still retain 1–5% enzyme activity [153].”
BackgroundPhase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia
Auchus, R. J., Hamidi, O., Pivonello, R., Bancos, I., Russo, G., Witchel, S. F., Isidori, A. M., Rodien, P., Srirangalingam, U., Kiefer, F. W., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2404656 · Cited by 79
Self-citation
Metadata
- Authors
- Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., Krone, N., Merke, D. P., Miller, W. L., Nordenström, A., Reisch, N., Sandberg, D. E., Stikkelbroeck, N. M. M. L., Touraine, P., Utari, A., Wudy, S. A., & White, P. C.
- Affiliations
- Department of Pediatric Endocrinology, Radboud University Medical Centre, Amalia Childrens Hospital, Nijmegen, The Netherlands
- Northwell Health (US)
- University of Glasgow (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University of Michigan (US)
- Karolinska University Hospital (SE)
- University of Bern (CH)
- Queen Mary University of London (GB)
- Technische Universität Dresden (DE)
- Radboud University Medical Center (NL)
- University Hospital Carl Gustav Carus (DE)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)
- University of California, San Francisco (US)
- LMU Klinikum (DE)
- Sorbonne Université (FR)
- Diponegoro University (ID)
- Justus-Liebig-Universität Gießen (DE)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- White, Perrin C
- ORCID
- Claahsen - van der Grinten, Hedi L
- Speiser, Phyllis W
- Ahmed, S Faisal
- Arlt, Wiebke
- Auchus, Richard J
- Falhammar, Henrik
- Flück, Christa E
- Guasti, Leonardo
- Huebner, Angela
- Krone, Nils
- Merke, Deborah P
- Miller, Walter L
- Nordenström, Anna
- Reisch, Nicole
- Sandberg, David E
- Touraine, Philippe
- Utari, Agustini
- Wudy, Stefan A
- White, Perrin C
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2021-05-07
- Volume
- 43
- Issue
- 1
- Pages
- 91-159
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W4229036110
- Semantic Scholar
- 1867a4639fab9f23f14102ccc6107c07963e64dc
- Cited by
- 556
- References
- 831
- Citations by year
- 2026: 102 · 2025: 125 · 2024: 149 · 2023: 97 · 2022: 68 · 2021: 14
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Endocrine Reviews (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institutes of Health (U01-HD083493)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, CYP21A2 mutations, cortisol production, steroidogenic pathway, newborn screening, steroid profiling, genotyping, cell therapy, gene therapy, long-term outcomes, disease registries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.